FDA approves Amgen's cholesterol drug Repatha
August 27, 2015 at 17:17 PM EDT
WASHINGTON, Aug 27 (Reuters) - The U.S. Food and Drug Administration on Thursday approved Amgen Inc's drug Repatha for patients with hereditary forms of high cholesterol and those at high risk of cardiovascular disease.